" class="no-js "lang="en-US"> PerkinElmer - Medtech Alert
Thursday, June 19, 2025
PerkinElmer | Pharmtech Focus

PerkinElmer

About PerkinElmer

PerkinElmer

PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Our dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately 3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Related Story

Anona Bamford Ph.D., PerkinElmer Applied Genomics, on Single-Cell RNA Sequencing

May 9 2023

In this interview with Anona Bamford from PerkinElmer at the 33rd ECCMID 2023 event, she […]

PerkinElmer Launches NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to Strengthen SARS-CoV-2 Surveillance

December 13 2021

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today […]

PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams

November 15 2021

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the […]

PerkinElmer Launches Next-generation Cell Image Analysis and Management Software to Streamline Drug Discovery Decision-making

October 18 2021

PerkinElmer, Inc., a global leading solutions provider in the life sciences, diagnostics, food and environmental […]